TABLE 3.
Potential diagnostic and prognostic metabolites of TSC-RAML.
| Metabolites | TSC vs. CY | TSC vs. S-AML | Post vs. Pre TSC | ||||||
|---|---|---|---|---|---|---|---|---|---|
| FC | p-value | AUC | FC | p-value | AUC | FC | p-value | AUC | |
| Lucyoside K | 6,657.429 | 4.883*10−51 | 1.0 | 73,025.948 | 1.443*10−56 | 1.0 | 0.662 | 1.26*10−3 | 0.76 |
| His Trp | 2,171.442 | 1.311 *10−31 | 1.0 | 36.0719 | 1.762*10−25 | 0.98 | 1.507 | 0.0483 | 0.68 |
| Pro Pro Glu Phe | 404.041 | 2.352*10−16 | 1.0 | 111.556 | 5.911*10−16 | 0.99 | 1.783 | 0.0377 | 0.67 |
| Inosine | 16.936 | 8.377*10−19 | 0.98 | 5.760 | 2.746*10−14 | 0.95 | 0.635 | 0.0240 | 0.67 |
| Dipropyl sulfide | 3.947 | 5.690*10−4 | 0.79 | 4.141 | 9.994*10−3 | 0.73 | 0.3487 | 0.0101 | 0.72 |
| S-Adenosylmethionine | 3.037 | 2.174*10−12 | 0.81 | 2.236 | 3.155*10−4 | 0.76 | 0.581 | 0.0256 | 0.71 |
| Gly Trp Glu Ser | 0.0671 | 3.920*10−10 | 0.94 | 0.0608 | 2.444*10−12 | 0.95 | 3.569 | 2.549*10−5 | 0.87 |
| Adenosine 3′-monophosphate | 0.105 | 8.144*10−17 | 0.96 | 0.0389 | 2.938*10−16 | 0.95 | 0.0565 | 0.0310 | 0.57 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | 0.1478 | 1.383*10−18 | 1.0 | 0.123 | 5.726*10−20 | 1.0 | 0.481 | 0.00613 | 0.71 |
| Gly Asp Ala Ala | 0.156 | 6.092*10−11 | 0.96 | 0.131 | 1.910*10−15 | 0.97 | 3.569 | 2.549*10−5 | 0.76 |
| Aspartyl-Tryptophan | 0.198 | 8.160*10−10 | 0.94 | 0.131 | 4.811*10−14 | 0.99 | 2.429 | 0.00145 | 0.79 |
| Ketotifen-N-glucuronide | 0.265 | 8.674*10−6 | 0.83 | 0.363 | 6.097*10−4 | 0.76 | 0.5145 | 6.686*10−4 | 0.75 |
| alpha-Terpineol formate | 0.547 | 1.776*10−8 | 0.91 | 0.524 | 6.846*10−7 | 0.87 | 0.6539 | 0.00913 | 0.70 |